Management of refractory dyspnoea: Evidence-based interventions

Cancer Forum

Volumn 34, Issue 2, 2010, Pages 86-90

  Davidson, Patricia M ^a   Currow, David C ^b  

^a CURTIN UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BENZODIAZEPINE; BRONCHODILATING AGENT; CHLORPROMAZINE; CORTICOSTEROID DERIVATIVE; DIHYDROCODEINE; DIURETIC AGENT; FENTANYL; FORMOTEROL; FUROSEMIDE; HYDROMORPHONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; LORAZEPAM; MIDAZOLAM; MORPHINE; OPIATE; OXYGEN; PHENOTHIAZINE DERIVATIVE; PIRBUTEROL ACETATE; PLACEBO; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; TERBUTALINE SULFATE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ACUPRESSURE; ACUPUNCTURE; ANXIETY DISORDER; ARTIFICIAL VENTILATION; BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; DROWSINESS; DRUG DOSE TITRATION; DRUG METABOLISM; DYSPNEA; EVIDENCE BASED PRACTICE; EXERCISE; EXTRAPYRAMIDAL SYMPTOM; HOSPITALIZATION; HUMAN; HYPOTENSION; HYPOXEMIA; MALIGNANT NEOPLASTIC DISEASE; MASSAGE; MUSCLE TRAINING; NAUSEA; OXYGEN THERAPY; PATIENT CARE; PATIENT COUNSELING; REFRACTORY DYSPNEA; RELAXATION TRAINING; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 77955383494     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Booth S, Bausewein C, Higginson I and Moosavi SH. Pharmacological treatment of refractory breathlessness. Expert Review of Respiratory Medicine. 2009;3(1):21-36.
2. Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR and Abernethy AP. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. Journal of Pain and Symptom Management. 2010;39(4):680-689.
3. Lansing RW, Gracely RH and Banzett RB. The multiple dimensions of dyspnea: Review and hypotheses. Respir Phystolo Neurobid. 2009;167(1):53-60.
4. Manning HL and Schwartzstein RM. Pathophysiology of dyspnea. New England Journal of Medicine. 1995; 333(23):1547-53.
5. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfeld RM. Validation of the Charison comorbidity index in patients with head and neck cancer: a multi-institutional study. The Laryngoscope. 2009;107(11):1469-1475.
6. Chao HH, Mayer T, Concato J, Rose MG, Uchio E, Kelly, WK, et al. Prostate Cancer, Comorbidity, and Participation in Randomized Controlled Trials of Therapy. Journal of Investigative Medicine. 2010;58(3):566-8.
7. Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, et al. Comorbidities, therapy and newly diagnosed conditions for women with early stage breast cancer. Journal of Cancer Survivorship. 2009; 3(2):89-98.
8. Blinderman C, Homel P, Andrew Billings J, Tennstedt S, Portenoy R. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. Journal Pain Symptom Management. 2009;38(1):115-123.
9. Doehner W, von Haehling S, Anker SD and Lainscak M. Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review. Wiener Klinische Wochenschrift. 2009;121(9):293-296.
10. Abernethy AP, Uronis HE, Wheeler JL, Currow DC. Management of dyspnea in patients with chronic obstructive pulmonary disease. WMW Wiener Medizinische Wochenschrift. 2009;159(23):583-590.
11. Carrieri-Kohlman V, Lindsey AM and West CM. Dyspnea in Pathological Phenomenon in Nursing. Saunders (Philadelphia) 2003:175-209.
12. Mularski RA, Campbell ML, Asch SM, Reeve BB, Basch E, Maxwell TL, et al. A Review of Quality of Care Evaluation for the Palliation of Dyspnea. American Journal of Respiratory Critical Care Medicine. 2010;181(6):534-538.
13. Bausewein C, Farquhar M, Booth S, Gysels M, Higginson I. Measurement of breathlessness in advanced disease: a systematic review. Respiratory Medicine. 2007;101(3):399-410.
14. Campbell ML, Templin T and Walch J. A respiratory distress observation scale for patients unable to self-report dyspnea. Journal of Palliative Medicine. 2010;13:1120-1123.
15. Johnson MJ, Oxberry SG, Cleland J and Clark AL. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. European Journal of Heart Failure. 2010;12(2):137.
16. Dorman S, Jolley C, Abernethy A, Currow D, Johnson M, Farquhar M, et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliative Medicine. 2009;23(3):213.
17. Currow DC, Ward AM and Abernethy AP. Advances in the pharmacological management of breathlessness. Current Opinion in Supportive and Palliative Care. 2009;3(2):103.
18. Jennings AL, Davies AN, Higgins JPT, Gibbs JSR and Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-944.
19. Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. Journal of Clinical Oncology. 2008;26(14):2396.
20. Varkey B. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine. 2010;16(2):150.
21. O'Mahony S, McHenry J, Blank AE, Snow D, Karakas SE, Santoro G, et al. Preliminary report of the integration of a palliative care team into an intensive care unit. Palliative Medicine. 2010;24:154.
22. McNicol E. Opioid Equianalgesic Conversions. Journal of Pain and Palliative Care Pharmacotherapy. 2009;23(4):458-458.
23. Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P. A prospective survey of the use of dexamethasone on a palliative care unit. Palliative Medicine. 2001;15(1):3.
24. Davidson P, Macdonald P, Pauli G, Rees D, Howes L, Cockburn J. Diuretic therapy in chronic heart failure: implications for heart failure nurse specialists. Australian Critical Care. 2003;16(2):59-69.
25. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007354. DOI: 10.1002/14651858.CD007354.pub2.
26. Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong R. The management of dyspnea in cancer patients: a systematic review. Supportive care in cancer. 2008;16(4):329-337.
27. Thomas JR. Management of Dyspnea. In: Ettinger DS, ed. Cancer and Drug Discovery Development: Supportive Care in Cancer Therapy. Totowa, NJ: Humana Press 2008:1-15.
28. Hallenbeck J, Kauser F and LeGrand SB. Theophylline for Unexplained Dyspnea in Palliative Medicine: A Case Report. Journal of Palliative Medicine. 2008;11(3):510-513.
29. Newton P, Davidson P, Macdonald P, Ollerton R and Krum H. Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? Journal of Pain and Symptom Management. 2008;36(4):424-441.
30. Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliative Medicine. 2009;23(4):309-16
31. Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP. Oxygen for relief of dyspnoea in mildly-or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. British Journal of Cancer. 2008;98(2):294-299.
32. Currow D, Abernethy A, Young I, Frith P, Crockett A and McDonald C. A double blind randomised study of oxygen versus air in oxygen naïve patients with refractory dyspnoea and PaO2>55. 2006-2008 National Health & Medical Research Council. 375127/National Institutes of Health R01 AG026469-01.
33. Chermont S, Quintão MM, Mesquita ET, Rocha NN, Nóbrega AC. Noninvasive Ventilation With Continuous Positive Airway Pressure Acutely Improves 6-Minute Walk Distance in Chronic Heart Failure. Journal of Cardiopulmonary Rehabilitation & Prevention. 2009;29(1):44.
34. Creagh-Brown BC and Shee C. Palliative and end-of-life care for patients with severe COPD. European Respiratory Journal. 2009;33(2):445.
35. Luce JM. End-of-Life Decision-making in the Intensive Care Unit. Am J Respir Crit Care Med. 2010, doi: 10.1164/rccm.201001-0071Cl.
36. Trappenburg JC, Koevoets L, de Weert-van Oene GH, Monninkhof EM, Bourbeau J, Troosters T, et al. Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulmonary Medicine. 2009 Dec 29;9:52.
37. Fried TR, Bullock K, Iannone L, O'Leary JR. Understanding advance care planning as a process of health behavior change. Journal American Geriatric Society. 2009 Sep;57(9):1547-55. Epub 2009 Aug 4.
38. Lavie CJ, Thomas RJ, Squires RW, Alison TG, Milani RV. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clinic Procedures. 2009;84(4):373-83.
39. Sachs S and Weinberg RL. Pulmonary rehabilitation for dyspnea in the palliative-care setting. Current Opinion in Supportive and Palliative Care. 2009;3(2):112.
40. Weiner P, Waizman J, Magadle R, Berar-Yanay N, Pelled B. The effect of specific inspiratory muscle training on the sensation of dyspnea and exercise tolerance in patients with congestive heart failure. Clinical Cardiology. 1999;22(11):727-32.
41. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial. J Clin Oncol. 2010 10;28(2):340-7. Epub 2009 Nov 30.
42. Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. American Journal of Respiratory Critical Care Medicine. 1996;154(1):6-17.
43. Jones RC, Harding SA, Chung MC, Campbell J. The Prevalence of Posttraumatic Stress Disorder in Patients Undergoing Pulmonary Rehabilitation and Changes in PTSD Symptoms Following Rehabilitation. Journal of Cardiopulmonary Rehabilitation & Prevention. 2009;29(1):49-56.
44. Cooper S, Oborne J, Newton S, Harrison V, Thompson Coon J, Lewis S, et al. Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled trial. Thorax. 2003;58(8):674-9.
45. Bowler SD, Green A, Mitchell CA. Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust. 1998;169(11-12):575-8.
46. Bernardi L, Sleight P, Bandinelli G, Cencetti S, Fattorini L, Wdowczyc-Szulc J, et al. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. British Medical Journal. 2001;323(7327):1446-9.
47. Filshie J, Penn K, Ashley S, Davis CL. Acupuncture for the relief of cancer-related breathlessness. Palliative Medicine. 1996;10(2):145-50.
48. Jobst K, Chen JH, McPherson K, Arrowsmith J, Brown V, Efthimiou J, et al. Controlled trial of acupuncture for disabling breathlessness. Lancet. 1986 Dec 20-27;2(8521-22):1416-9.
49. Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, et al. Randomized Controlled Trial of Mindfulness-Based Therapy for Dyspnea in Chronic Obstructive Lung Disease. J Altern Complement Med. 2009;15(10):1083-90.
50. Corbin LW, Mellis BK, Beaty BL, Kutner JS. The Use of Complementary and Aternative Medicine Therapies by Patients with Advanced Cancer and Pain in a Hospice Setting: A Multi-centered, Descriptive Study. Journal of Palliative Medicine. 2009;12(1):7-8.
51. Sedeno MF, Nault D, Hamd DH, Bourbeau J. A self-management education program including an action plan for acute COPD exacerbations. COPD. 2009;6(5):352-8.
52. Schaefer KM, Shober Potylycki MJ. Fatigue associated with congestive heart failure: use of Levine's Conservation Model. Journal of Advance Nursing. 1993;18(2):260-8.